have demonstrated biocompatibility and effectiveness to reduce bioburden. 14 Antiseptics used in current wound dressings include silver, iodine, polyhexamethylene biguanide (PHMB), and natural tannins, as in the product Oakin (Amerx Health Care Corporation, Clearwater, Florida). Silver, used for thousands of years as an antimicrobial agent, exerts antimicrobial effects when binding occurs at the bacterial cell wall. Cell death occurs when the silver ion binds to proteins involved in respiration and nutrition of the organism or when binding to DNA, thus affecting replication and division of the organism. 15 SSD creams do not require a high amount of silver to be effective, but these products must contact the wound on a consistent basis so that the discharged silver ions can stay active in the wound over time at concentrations that are effective. As the silver ions are rapidly neutralized in the wound, regular applications of the product, as suggested, every 12 hours, must occur to maintain the bactericidal effect. 16 Although more recent advancements in wound dressings have led to the ability to deliver silver in more accurate levels over an extended period, many silver products on the market deliver silver at levels that are not always clearly defined, raising concerns for cytotoxicity. Studies have demonstrated that delayed wound healing or inhibition of wound epithelialization after the use of certain topical silver dressings can produce cytotoxic effects on both cultured keratinocytes and fibroblasts. As cytotoxicity correlates directly with the amount of silver released from the specific wound dressing (measured by silver concentration in the culture medium), caution should be exercised in using silver-based dressings. 17, 18 Delivery systems and wound indications may vary; Table 1 lists commonly used antimicrobial dressings on the market. Prisma (Systagenix Wound Management, Quincy, Massachusetts) is an antimicrobial dressing that is 55% type I bovine collagen and 44% oxidized regenerated cellulose with impregnated silver. This dressing has the activities of type I bovine collagen in an antimicrobial dressing and would be selected for the purposes of the antimicrobial activity in addition to the benefits of intact collagen on the wound healing.
Oakin, a naturally existing antimicrobial agent derived from oak extract, contains tannins that possess antimicrobial properties. Its mode of antimicrobial action is related to its ability to inactivate microbial adhesins, enzymes, and cell envelope transport proteins. 19, 20 Oakin is thought to act locally by assisting in the migration of fibroblasts to the wound bed, decreasing the permeability of bacterial cell membranes, and exerting anti-inflammatory properties. Oakin is available as either an amorphous hydrogel (AmeriGel Wound Dressing) or as a nonwoven 4-ply 2'' Â 2'' pad (AmeriGel hydrogel saturated gauze dressing). The unique characteristic of this dressing lies in its ability to provide consistent moisture to the wound for up to 7 days with no maceration as a result of a polyethylene glycol base (polyethylene glycol 400 and polyethylene glycol 3350). The polyester/rayon blend gauze has the ability to absorb excess wound fluid (up to 10 times its weight) into its fibers while maintaining a moist wound environment. This pliable dressing provides excellent conformability to the wound bed and a bacterial barrier. One in vitro time-kill study showed that the Oakin product reduced methicillin-resistant Staphylococcus aureus (MRSA) 99.2% in 24 hours. 21 The nonwoven 4-ply 2'' Â 2'' pad impregnated with Oakin was studied as a tool to use as a primary dressing over bioengineered alternative tissues, demonstrating rapid healing times. 22 The product's ability to maintain moisture and actively provide an antimicrobial barrier was identified as reasons for the reduced healing times. Although not claiming antibacterial properties like Oakin, another oak extract product available commercially is polyhydrated ionogen (PHI), a patented blend of cations found naturally in the body, including potassium, zinc, calcium, and rubidium, in a mixture of polyethylene glycols and citric acid. Commercially, PHI is available in Europe as the wound dressing material Dermax (Greystone Pharmaceuticals, Inc, Fort Myers, Florida) and can also be found in Tegaderm matrix dressing with PHI (3M, St Paul, Minnesota). It has been shown that PHI has a positive influence on wound healing when applied in chronic wounds that were not responding to conventional therapeutic interventions. The proposed benefit of PHI is to alter the Table 1 .
EXAMPLES OF COMMONLY USED ANTIMICROBIAL DRESSINGS
overproduction of matrix metalloproteinases (MMPs) that are naturally produced in response to tissue damage. 23 In chronic wounds, MMPs are overproduced, resulting in the breakdown and destruction of newly regenerated tissue. This abnormal response either results in slow healing of the wound or prevents healing altogether. In the wounds formed during insertion of a medical device, this abnormal response has the potential to negatively interfere with the body's acceptance of the medical implant, resulting in the wounds resisting healing. The PHI formulation is found to act locally at the injured tissue by affecting MMP levels. More specifically, the PHI formulation downregulates MMP levels, which helps to restore the environment in and around the wound and promote a more normal wound-healing response. Thus, the PHI formulation would be advantageous for treating wounds, resulting from the insertion of a medical implant, thereby improving the probability of implant acceptance by the surrounding tissue. Because PHI is a water-soluble ionic substance, application of the compound must be reapplied frequently to maintain a controlled release. 24 
METHODS

An in vitro inhibition of growth test (corrected zone of inhibition [CZOI]
) was chosen to determine the antibacterial properties of 3 common silver antimicrobial dressings and an Oakin antimicrobial dressing. A sterile gauze pad was used as a control. All of the dressings were sterile and were used as supplied by the manufacturer. The 4 dressings studied were Prisma, Acticoat 7 (Smith & Nephew, St. Petersburg, Florida), Aquacel Ag (ConvaTec, Skillman, New Jersey), and AmeriGel saturated gauze dressing. A CZOI test was used, which, in essence, is the same as a standard zone of inhibition test except that the sizes of the zones were corrected to take into account the differences in shape and size of the hand-cut pieces of test material. In these cases, the dressings were cut into 1 Â 1-cm squares and placed on lawns of bacterial cultures: S aureus, MRSA, and Pseudomonas aeruginosa, seeded on Mueller Hinton agar plates (Difco, Chicago, Illinois). Product squares were coded as follows: A = Prisma, B = AmeriGel, C = Acticoat 7, D = Aquacel Ag, and E = gauze. The technologist was not aware of product names when conducting the test.
The bacterial lawns were incubated for 24 hours, and the CZOI was determined by measuring the zone of clearing across one direction of the test article and subtracting the exact width of the test article (Table 2 ). This was done in 2 perpendicular directions across the dressing, and the results averaged to yield the final value. Thus, the CZOI reflects only the width of the zone of clearing surrounding the test article and is corrected for variances in the exact size of the individual test articles. The CZOI was measured, and the process repeated for 48 hours (Table 3 ). This test is a modification of the standard Kirby-Bauer test for susceptibility of the test organism to the tested antimicrobial agent. In addition, the test also provides a measure of the ability of the antimicrobial agent to diffuse into the surrounding agar medium, producing larger or smaller zones of inhibition dependent on the release and migration of the antimicrobial agent in the medium.
A cost analysis (Table 4 ) was performed evaluating the average cost for each of the above antimicrobial wound dressings, based on a review of the prices recorded from 3 widely known vendors. The average cost was calculated for the average cost per application.
RESULTS
In Vitro Antimicrobial Efficacy
This study was able to provide determination of the ability of each antimicrobial dressing to inhibit the growth of bacteria in the area immediately surrounding the dressing. The results shown in Table 2 indicate that all of the products (with the exception of the control) were able to produce a comparable zone of inhibition around each dressing piece for 24 hours and that the activity was maintained for at least 48 hours, as shown in Table 3 .
As is evident by the CZOI, AmeriGel demonstrated effective inhibition with no substantial difference between the silver products and the AmeriGel. Although the mode of action of certain types of antimicrobial dressings differs, the above results demonstrate that all of the products studied had the capability to release their antimicrobial ingredient (silver ions vs tannin) into the medium. In a recent study, a silver antimicrobial product was tested alongside a cottonimpregnated gauze with 0.2% PHMB (Kerlix AMD; Tyco-Kendall Healthcare, Mansfield, Massachusetts). In this study, the Kerlix AMD gauze did not produce a zone of inhibition, whereas Acticoat 7 produced a CZOI of 11.7 mm against S aureus after 24 hours. 14 These findings suggested that the antimicrobial activity associated with Kerlix AMD gauze was tightly bound to the dressing and not released into the surrounding medium. The results of this study demonstrated that although both the studied dressings conveyed powerful antimicrobial activities when tested against various isolates, the activity of the PHMB dressing appeared dependent on the microbes being in close proximity to the dressings. This is suggested by the results of the zone of inhibition experiments that indicate that there is little apparent diffusion of the antimicrobial activity away from the dressing. In the authors' CZOI test, both the silver ion and the concentrated tannins within the saturated gauze product were clearly diffused into the surrounding medium.
In the cost analysis performed, shown in Table 4 , several points should be noted. There is a significant price difference between the silver products and the Oakin-impregnated nonwoven 4-ply 2'' Â 2'' pad. The frequency of application may vary, but the frequency of application for this study is as defined in the tables by the authors of this article. The average cost difference per application between the Oakin product and the least expensive silver product was $6.96 per application. After 3 weeks, the difference between the Oakin-impregnated gauze pad and the least expensive silver antimicrobial dressing was $20.88, whereas after 7 weeks, the difference was $48.72. The difference between the Oakin product and the most expensive of the silver dressings (Prisma) was $783.93. The most significant finding was the total cost of application after 7 weeks in utilization (Table 5) . When these costs are multiplied for 100 patients, one can see the impact in a greater hypothetical patient populous (Table 6 ). These numbers, when graphed out, better demonstrate the overall impact the cost of dressings alone has on healthcare ( Table 7) .
DISCUSSION Oakin Versus PHI
Although the purpose of this article was to explore the antimicrobial properties of current commercially available wound dressings and the economic impact thereof, further discussion to clarify the mode of action of oak extract products would be of benefit to the reader. Even though Oakin and PHI are derived from oak extract, there are significant differences between them. Oakin relies on the activity of tannins (tannic acid), which possess antimicrobial and MMP-modulating properties. 25 PHI, on the other hand, relies on the activity of zinc, among other divalent metal ions (copper, cadmium, nickel, calcium), which are presumed to correct the imbalance between MMPs and MMP inhibitors through the inhibition of proteinases. The effect of PHI on gene expression, including synthesis of MMPs, was studied in cultures of dermal fibroblasts from normal and diabetic patients and showed that PHI decreased MMP-2 mRNA and increased TIMP (tissue inhibitor of metalloproteinase) mRNA levels. 24 Among the commercially available products using PHI, there are no claims of antimicrobial activity; however, there have been studies demonstrating that at least some of the components of PHI may possess some antimicrobial activity (ie, zinc oxide has been shown to inhibit plasma coagulation by S aureus cells and inhibit the formation of biofilms under specific conditions); however, at this juncture, there appear to be no studies demonstrating antimicrobial activity with PHI. 24, 25 Tannins, on the other hand, have long been linked to antimicrobial activity. The antimicrobial mechanisms of tannins can be summarized as follows: The astringent properties of tannins have been shown to induce complexation or inhibition of microbial enzymes or substrates. Tannins have been shown to demonstrate toxicity upon the membranes of microorganisms. 26 Complexation of metal ions by tannins, accounting for the inhibitory effect of tannic acid, is demonstrated by the inhibition of the growth of intestinal bacteria, such as Bacteroides fragilis, Clostridium perfringens, Escherichia coli, and Enterobacter cloacae, among others. 27, 28 Tannic acid has a much greater relative binding efficiency to iron, and as microorganisms growing under aerobic conditions need iron for a variety of functions, including reduction of the ribonucleotide precursor of DNA, and other essential purposes, the inhibitory effect of tannic acid can be caused by its strong iron-binding capacity. 29, 30 In a recent article, 6 tannins were studied, all of which inhibited the plasma coagulation of S aureus, demonstrating that the inhibition of plasma coagulation by tannic acid is due to a decrease in the concentration of ionic calcium, inhibition of enzyme production, and hindrance of the enzyme reaction. 31 The presence of a fibrin-rich biofilm is a well-known factor responsible for prolonging S aureus infections. The biofilm of S aureus is reinforced with fibrin fibers, making it more durable than other bacterial biofilms. If plasma coagulation does not occur in the presence of some tannins, the formation of fibrin-rich membranous structures by S aureus will be inhibited. 32 
Tannins and MMP Activity
In addition to their antimicrobial activity, research has also demonstrated that tannins have the ability to modulate the damage that MMPs inflict on the gastrointestinal mucosa in ulcerative colitis (UC). Studies indicate that UC patients show increased levels of MMP-9 and MMP-3, which are known to contribute significantly to the intestinal inflammation seen clinically. Condensed tannins have been shown to suppress the secretion of MMP-2 and MMP-9 in Caco-2 cells. The Caco-2 cell line is a line of heterogeneous human epithelial colorectal adenocarcinoma cells, developed by the Sloan-Kettering Institute for Cancer Research, for in vitro studies on absorption rates of compounds across the intestinal epithelial cell barrier. In research conducted with condensed tannins isolated from cranberries, MMP production and catalytic activity were both inhibited. [33] [34] [35] Although the anti-inflammatory impact of tannins has been well described, studies have also demonstrated that tannins inhibit MMPs in a similar, yet ill-defined way like that of PHI. 36 With tannin's ability to exert an anti-inflammation effect, especially on macrophages, the expression of some cytokines, which usually act as an inflammatory mediator to stimulate macrophages to express MMPs, is inhibited. [37] [38] [39] As wounds are in a constant state of evolution, addressing bacterial imbalance often requires utilizing more than 1 treatment modality or even combining treatment modalities during the course of a chronic ulceration. Systemic or oral antibiotics should be considered the first line of therapy for complicated skin infections with clinical signs of cellulitis, leukocytosis, or fever; however, antimicrobial dressings can be used in conjunction with systemic therapy. Antimicrobial dressings are composed of a variety of different core materials to which antimicrobial agents are added. These antimicrobial dressings can vary significantly in price and efficacy, depending on the characteristics of the core materials and the potency of the antimicrobial agents. The purported benefits of these antimicrobial dressings are that they may reduce the presence of pathogens and decrease the risk of infection while creating a wound bed that will allow for the normal pathway of wound repair. 40, 41 Despite a wide variety of silver dressings available and various in vitro responses from these dressings, randomized trials to support the clinical benefits of silver are lacking. Several key questions must be asked to choose the right dressing to assist in managing wound infection and reducing the risk of infection: & Will the dressing be able to balance the moisture needs of the wound? & Will the dressing provide an effective antimicrobial barrier? & Is the dressing appropriate based on the size, depth, and location of the wound? & Does the dressing conform well and stay in contact with the wound surface? & Is the dressing cost-effective? Are there dressings of equal efficacy that cost less?
Each of the products chosen for this study has its own unique advantages, depending on the type of wound encountered. For instance, a deeper wound with moderate drainage may be better suited with Prisma or Aquacel Ag, whereas a full-thickness ulcer with less depth and more dryness would clearly benefit more from the Acticoat 7 or Oakin-impregnated product.
It is widely accepted that best practice in chronic wound care begins with moist wound healing. A moist wound environment in combination with an antimicrobial agent will reduce pain, facilitate more rapid cell migration, and provide better healing rates than dressings that have a tendency to overdry the wound bed. Dressings such as the Oakin-impregnated gauze provide the unique combination of moist wound healing along with an antimicrobial efficacy.
The ability of some silver-based products to absorb exudate better than the Oakin-impregnated gauze product is primarily due to their mesh/foam construction. Wounds with low exudate or ulcers over bony prominences (toes or malleoli) would benefit from the Oakin-impregnated gauze product because of its pliability and conformability to the tissues and the addition of a moisture-retaining dressing. Although the Oakin-impregnated gauze product does absorb some exudate, it would not be indicated in wounds with moderate to heavy drainage.
The ability of a dressing to conform to the contours of a wound is critical to prevent areas of noncontact, where bacterial proliferation may occur. For antimicrobial dressings, such as those containing silver, a high degree of conformability to uneven wound surfaces is critical to ensure effectiveness of the antimicrobial dressing at the wound-dressing interface. Although studying the conformability of each of the above dressings to human tissue or the agar plates was not within the scope of this study, this is a critical area that should be taken into consideration when choosing the right wound dressing.
In a previous study, the conformability of 2 silver products (Acticoat 7 and Aquacel Ag) was studied against human wound tissue and dried dermal membrane. 42 It was determined that Aquacel Ag had a much better conformability to the studied surfaces than the Acticoat 7 primarily because of the mesh fibers that were able to form a gel over the wound surface. Thomas and McCubbin 43, 44 looked at the effectiveness of various silver-containing products using 3 methodsVzone of inhibition, challenge testing, and microbial transmission testingVto demonstrate differences in the various dressings. Results demonstrated that the polyethylene mesh (Aquacel Ag) had the most rapid antimicrobial effect due to its rapid release of silver. Although most of the dressings had some impact on the bacteria studied, the speed of onset and wound surface activity varied.
Although there are many factors that affect how the dressing conforms or contacts the wound surface, the better conformability of a dressing to the wound surface (such as in the case of polyethylene mesh in Aquacel Ag), the better the antimicrobial effect. Furthermore, some dressings release their antimicrobial contents into the surrounding medium more readily than others, whereas some dressings (such as the PHMB dressing) demonstrate no activity beyond their own borders, yet have potent bactericidal effects in the wound. 44 Table 7 .
TOTAL COST PER APPLICATION OVER A 7-WEEK PERIOD (COST OF DRESSING ONLY FOR 100 PATIENTS)
Column1
Week 1 
CONCLUSIONS
The estimated cost for the treatment of a single chronic wound, including services and associated products, is close to $40,000 or, in some cases, even more 45 (Table 7) . Any further delay, no matter the cause, would certainly increase this cost. The easier the dressing is to use at home, the better the compliance and healing time. Products that can be dispensed to the patient directly (avoiding the risk of the patient not getting the dressing at the pharmacy or medical supply store) can further reduce delays in treatment and improve compliance.
With the rising cost of healthcare associated with wound care, reducing healing times utilizing a rational and evidence-based approach should be of prime importance to the wound care provider. Although, in some cases, higher initial costs for wound care products can be justified to reduce healing times, economic discretion is important when assessing cost versus efficacy when using products that work comparably. The differences in cost per application and frequency of applications per week should be taken into consideration. The authors do subscribe to the idea of using the best products available for the needs of the patient; however, choosing a product indicated for the same wound type that costs significantly more than a comparable, less expensive product, for any reason, should be discouraged.
The results of this study indicate there may be little clinical difference in the efficacy of many silver-containing wound dressings available on the market. Although the CZOI test demonstrated a slightly increased bactericidal activity with the silver products, there was no observable substantial difference in comparison with the Oakin product. The results do suggest that the biggest differences between many antimicrobial dressings on the market may be more in cost than in antimicrobial efficacy. Some products, such as Prisma, offer the benefits of collagen in the wounds and that has multiple wound healing effects. The differences in cost are due to variances in cost per application and frequency of applications per week.
Taking into consideration the lack of a substantial difference in the CZOI measurements among the antimicrobial dressings chosen for this study and the costs associated with these dressings, this study should help guide the practitioner toward selecting the most efficacious and economical wound dressing to reduce wound healing times. Further investigation, evaluating the in vivo activity of these and other dressings for their benefit in wound healing and wound infection prevention, is suggested to advance the information available for decision making of the practitioner when choosing one dressing over another. &
